Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Qing-gan-jian-pi decoction is a Traditional Chinese Medicine (TCM) herbal formula developed by the Xi'an Hospital of Traditional Chinese Medicine for the treatment of Barrett's esophagus. The formula is designed based on the TCM principles of clearing liver heat (Qing Gan) and strengthening the spleen (Jian Pi), which addresses the underlying disharmony often observed in patients with chronic gastroesophageal reflux. It aims to alleviate clinical symptoms such as heartburn and acid regurgitation while promoting the repair of the esophageal mucosa. Clinical research conducted at the hospital suggests that the decoction may modulate inflammatory pathways, including the inhibition of cyclooxygenase-2 (COX-2) and various pro-inflammatory cytokines, thereby potentially reducing the risk of progression from Barrett's esophagus to esophageal adenocarcinoma.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on qing-gan-jian-pi decoction.